MedTrace Logo

Adjunctive Benefit of a Xenogenic Collagen Matrix

NCT03833765 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-02-12

No results posted yet for this study

Summary

The present CONSORT-based randomized clinical trial is to assess the adjunctive benefit of a xenogenic collagen matrix in combination with a coronal advanced flap with respect to a coronal advanced flap alone in the treatment of multiple gingival recession defects in adult population.

Conditions

  • Gingival Recession

Interventions

PROCEDURE

CAF+XCM

After flap elevation according to the Coronally Advanced Flap procedure for multiple recession defects, a Xenogeneic Collagen Matrix was applied and then covered by the flap.

PROCEDURE

CAF alone

Coronally Advanced Flap procedure alone was performed to treat multiple recession defects

Sponsors & Collaborators

  • Geistlich Pharma AG

    collaborator INDUSTRY

  • Roberto Rotundo

    lead INDIV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-28
Primary Completion
2016-05-03
Completion
2017-07-17

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833765 on ClinicalTrials.gov